Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398813 · ClinicalTrials.gov registry record
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 500
- Enrollment target
NCT01398813 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 500 participants.
The verdict
NCT01398813 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
In this survey of X-Lined Hypohidrotic Ectodermal Dysplasia (XLHED) carrier females, Edimer proposes to review responses to an XLHED Carrier Outlook toward Reproduction Survey in order to understand attitudes toward reproduction, potential treatments and genetic testing in order to improve the understanding of the decisions that XLHED carrier females make regarding their reproductive future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01398813
The ClinicalTrials.gov registry entry for NCT01398813 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01398813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01398813 about?
NCT01398813 is a clinical study titled "X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey". In this survey of X-Lined Hypohidrotic Ectodermal Dysplasia (XLHED) carrier females, Edimer proposes to review responses to an XLHED Carrier Outlook toward Reproduction Survey in order to understand attitudes toward reproduction, potential treatments and genetic testing in order to improve the under...
What is the current status of trial NCT01398813?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2011-07. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01398813?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.